Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07876674 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase III Clinical Trial Evaluating SR604 Injection for Prophylactic Treatment in Patients With Hemophilia

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a single-arm, multicenter Phase III clinical trial designed to evaluate the efficacy and safety of prophylactic treatment with SR604 Injection in hemophilia A/B patients with or without inhibitors.
Trial Details
NCT Number NCT07876674
Lead Sponsor Shanghai RAAS Blood Products Co., Ltd.
Conditions
(from sponsor)		 Hemophilia A, Hemophilia A and B, Hemophilia B
Related terms Hemophilia A, Hemophilia B
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov